685 related articles for article (PubMed ID: 34103704)
1. Cancer stem cell-immune cell crosstalk in tumour progression.
Bayik D; Lathia JD
Nat Rev Cancer; 2021 Aug; 21(8):526-536. PubMed ID: 34103704
[TBL] [Abstract][Full Text] [Related]
2. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
Plaks V; Kong N; Werb Z
Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
[TBL] [Abstract][Full Text] [Related]
3. Macrophages and cancer stem cells: a malevolent alliance.
Allavena P; Digifico E; Belgiovine C
Mol Med; 2021 Sep; 27(1):121. PubMed ID: 34583655
[TBL] [Abstract][Full Text] [Related]
4. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
[TBL] [Abstract][Full Text] [Related]
6. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
Madden EC; Gorman AM; Logue SE; Samali A
Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
[TBL] [Abstract][Full Text] [Related]
7. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
Clara JA; Monge C; Yang Y; Takebe N
Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
[TBL] [Abstract][Full Text] [Related]
9. The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer.
Ferguson LP; Diaz E; Reya T
Trends Cancer; 2021 Jul; 7(7):624-634. PubMed ID: 33509688
[TBL] [Abstract][Full Text] [Related]
10. An emerging role for cellular crosstalk in the cancer stem cell niche.
Oshimori N; Guo Y; Taniguchi S
J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.
Khosravi N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Shahgoli VK; Hemmat N; Safarzadeh E; Baradaran B
Life Sci; 2020 Sep; 256():118005. PubMed ID: 32593711
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets.
Müller L; Tunger A; Plesca I; Wehner R; Temme A; Westphal D; Meier F; Bachmann M; Schmitz M
Front Immunol; 2020; 11():140. PubMed ID: 32117287
[TBL] [Abstract][Full Text] [Related]
13. Immunologic Targeting of Cancer Stem Cells.
Zhang J; Li Q; Chang AE
Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
[TBL] [Abstract][Full Text] [Related]
14. Influence of Innate Immunity on Cancer Cell Stemness.
Pastò A; Consonni FM; Sica A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397392
[TBL] [Abstract][Full Text] [Related]
15. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
[TBL] [Abstract][Full Text] [Related]
16. Immunology of cancer stem cells in solid tumours. A review.
Maccalli C; Volontè A; Cimminiello C; Parmiani G
Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
[TBL] [Abstract][Full Text] [Related]
17. How do tumor stem cells actively escape from host immunosurveillance?
Qi Y; Li RM; Kong FM; Li H; Yu JP; Ren XB
Biochem Biophys Res Commun; 2012 Apr; 420(4):699-703. PubMed ID: 22465008
[TBL] [Abstract][Full Text] [Related]
18. Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?
Vahidian F; Duijf PHG; Safarzadeh E; Derakhshani A; Baghbanzadeh A; Baradaran B
Immunol Lett; 2019 Apr; 208():19-29. PubMed ID: 30862442
[TBL] [Abstract][Full Text] [Related]
19. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells as key drivers of tumour progression.
Ayob AZ; Ramasamy TS
J Biomed Sci; 2018 Mar; 25(1):20. PubMed ID: 29506506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
